Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Ann Surg. 2021 Dec 1;274(6):1058–1066. doi: 10.1097/SLA.0000000000003770

TABLE 6.

Clinicopathologic Features of Patients Who Received Adjuvant Chemotherapy or Chemotherapy Followed by Radiation After Upfront Resection of Pancreatic Cancer

Categorical Variable Chemo Chemo-RT P Value
Median survival (mo) 42.7 54.6 0.247
Grade
  1 70 (13.6%) 72 (14.1%) 0.418
  2 298 (58.0%) 296 (57.8%)
  3 142 (27.6%) 134 (26.2%)
  4 4 (0.8%) 10 (1.9%)
Stage
  1 173 (32.0%) 164 (30.3%) 0.840
  2 367 (67.8%) 376 (69.5%)
  3 1 (0.2%) 1 (0.2%)
T
  1 52 (9.7%) 44 (8.3%) 0.418
  2 118 (22.1%) 116 (21.8%)
  3 363 (68.0%) 371 (69.7%)
  4 1 (0.2%) 1 (0.2%)
Comorbidities
  No 356 (65.8%) 361 (66.7%) 0.748
  Yes 185 (34.2%) 180 (33.3%)
Tumor size (mm) 36.1±61.8 33.9±45.2 0.517
# of examined nodes 14.9±9.2 14.9±8.9 0.976

Cohort of propensity score matching of patients with no high-risk features (negative margin, no nodal involvement, and no lymphovascular invasion).

All the treatments are in the adjuvant setting. Categorical variables presented in number (%) and continuous variables presented as meanstandard deviation.

Chemo indicates chemotherapy; Chemo-RT, chemotherapy followed by radiation.